Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00261560
Status:
COMPLETED
Last Update Posted:
2011-06-29
First Post:
2005-12-02
Brief Title:
A Safety and Effectiveness Study of Acetaminophen Extended Release 3900 mgDay and Ibuprofen 1200 mgDay in the Treatment of Pain Associated With Ankle Sprains
Sponsor:
Johnson Johnson Consumer and Personal Products Worldwide
Organization:
Johnson Johnson Consumer and Personal Products Worldwide
Study Overview
Official Title:
A Randomized Double-Blind Parallel-Group Study Comparing the Safety and Effectiveness of Acetaminophen Extended Release 3900 mgDay and Ibuprofen 1200 mgDay in the Treatment of Ankle Sprains
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the safety and effectiveness of 1300 mg acetaminophen extended release given three times daily for nine days to that of 400 mg ibuprofen given three times daily for nine days for the signs and symptoms of Grade I and Grade II lateral ankle sprains
Detailed Description:
The objective of this randomized double-blind parallel-group study is to compare the safety and effectiveness of 1300 mg acetaminophen extended release given three times daily for nine days to that of 400 mg ibuprofen given three times daily for nine days for the signs and symptoms of Grade I and Grade II lateral ankle sprains The primary efficacy endpoint is the change from baseline Day 1 to Day 4 in the subjects pain upon walking Safety assessments consist of the monitoring of adverse events and assessments of the ankle injury during the course of the study Two hypotheses are examined using a step down approach The first hypothesis is that acetaminophen extended release is not inferior to ibuprofen in relieving the pain associated with Grade I or Grade II lateral ankle sprains If acetaminophen extended release is not inferior to ibuprofen in relieving the pain associated with Grade I or Grade II lateral ankle sprains the second hypothesis is that acetaminophen extended release is superior to ibuprofen in relieving the pain associated with Grade I or Grade II lateral ankle sprains Two acetaminophen 650 mg extended release caplets taken by mouth three times a day for nine days or two ibuprofen 200 mg caplets taken by mouth three times a day for nine days
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None